Skip to content

A retrospective study on the response to radioactive iodine therapy in patients with positive and negative tumor deposits after surgery for differentiated thyroid cancer

A retrospective study on the response to radioactive iodine therapy in patients with positive and negative tumor deposits after surgery for differentiated thyroid cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600129440
Enrollment
Unknown
Registered
2026-08-05
Start date
2026-08-05
Completion date
Unknown
Last updated
2026-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Differentiated Thyroid Cancer

Interventions

Patients were grouped into the excellent response (ER) group and the non-ER group (suboptimal response), the latter including indeterminate response (IDR), biochemical incomplete response (BIR), and s

Sponsors

Shanxi Bethune Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients underwent total thyroidectomy or subtotal thyroidectomy and pathologically confirmed DTC; 2. Clinicopathologic data were sufficient; 3. At least one postoperative RAI administration; 4. The follow-up time was more than 6 months, with complete data for response assessment.

Exclusion criteria

Exclusion criteria: 1. The level of thyroid globulin an ody (TgAb) is greater than 115.00 KIU/L; 2. During the follow-up period, the lesion underwent surgical treatment, or received targeted therapy, radiotherapy, or other measures that might affect the assessment of radioactive iodine therapy (RAI).

Design outcomes

Primary

MeasureTime frame
Serological indicators-Thyroid function test;Response to radioactive iodine therapy.;

Countries

China

Contacts

Public ContactLiu Ye

Shanxi Bethune Hospital

liuye1829@163.com+86 351 8379291

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 25, 2026